Method for the treatment of cardiac and of vascular hypertrophy

Details Method for the treatment of cardiac and of vascular hypertrophy Method for the treatment of cardiac and of vascular hypertrophy

1991-11-14

1993-08-17

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514396, 5142312, 5142315, 514381, A61K 31415, A61K 31535, A61K 3141

Patent

active

052369439

ABSTRACT:
The invention relates to a method for the treatment of cardiac and of vascular hypertrophy and/or hyperplasia by administration of angiotensin II receptor blockers, preferably of the imidazole, pyrrole, pyrazole, triazole or tetrazole type.

REFERENCES:
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 4916129 (1990-04-01), Carini et al.
patent: 4975444 (1990-12-01), Danilewicz et al.
"The Discovery of Potent Nonpeptide Angiotensin II Receptor Antagonists: A New Class of Potent Antihypertensives" by J. V. Duncia et al., J. Med. Chem. (1990) vol. 33, pp. 1312-1329.
"Nonpeptide Angiotensin II Receptor Antagonists. IV. EXP6155 and EXP6803" by P. C. Wong et al., Hypertension vol. 13, No. 5 (1989) pp. 489-497.
"Nonpeptide Angiotensin II (AII) Receptor Antagonists: Studies With EXP9270" by P. C. Wong et al., Hypertensio vol. 14, No. 3 (1989) p. 348.
"Hypotensive Action of DuP 753, an Angiotensin II Antagonist, in Spontaneously Hypertensive Rats" by P. C. Wong et al., Hypertension vol. 15, No. 5 (1990) pp. 459-468.
"EXP 6803, A Nonpeptide Angiotensin II Receptor Antagonist" by P. C. Wong et al., Cardiovascular Drug Reviews vol. 7, No. 4 (1989) pp. 285-300.
"Two Distinct Angiotensin II Receptor Binding Sites in Rat Adrenal Revealed by New Selective Nonpeptide Ligands" by R. S. L. Chang et al., Molecular Pharmacology vol. 29 (1990) pp. 347-351.
"Antihypertensive Mechanism of Captopril in Renal Hypertensive Rats: Studies with a Nonpeptide Angiotensin II Receptor Antagonist and an Angiotensin II Monoclonal Antibody" by P. C. Wong et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 250, No. 2 (1989) pp. 515-522.
"Nonpeptide Angiotensin II Receptor Antagonists. III. Structure-Function Studies.sup.1 " by A. T. Chiu et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 250, No. 3 (1989) pp. 867-874.
"Nonpeptide Angiotensin II Receptor Antagonists. VII..sup.1 Cellular and Biochemical Pharmacology of DuP 753, an Orally Active Antihypertensive Agent" by P. C. Wong et al., The Journal of Pharmacology and Experimental Therapeutics, vol. 252, No. 2 (1990) pp. 711-718.
"Nonpeptide Angiotensin II Receptor Antagonists. VIII..sup.1 Characterization of Functional Antagonism Displayed by DuP 753, and Orally Active Antihypertensive Agent" by P. C. Wong et al., The Journal of Pharmacology and Experimental Therapeutics vol. 252, No. 2 (1990) pp. 719-725.
"Nonpeptide Angiotensin II Receptor Antagonists. IX..sup.1 Antihypertensive Activity in Rats of DuP 753, and Orally Active Antihypertensive Agent" by P. C. Wong et al., The Fournal of Pharmacology and Experimental Therapeutics vol. 252, No. 2 (1990) pp. 726-732.
Devereux et al., J. Clin Hypertens 1987: 3:87-103.
Dzau et al., Hypertension, vol. 18, No. 4, Oct. 1991, pII-100-104.
Sachinidis et al., Journal of Hypertension 1991, 9 (suppl 6):S226-S227.
Linz et al., Journal of Hypertension 1991, 9 (suppl 6):S400-S401.

Affiliated with

Also associated with

Rating

Method for the treatment of cardiac and of vascular hypertrophy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of cardiac and of vascular hypertrophy , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of cardiac and of vascular hypertrophy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2243977